ascentage.com (AAPG) Quick Liquidity

AAPG (Ascentage Pharma Group) - company brandmark

The implementation of AI molecule modeling is accelerating target discovery, which confirms the recorded level of high liquidity for Ascentage Pharma Group (AAPG). The value of 1.21 determines this parameter level. Financial stability is supported by partnerships with distributors to reduce costs. The strategy is based on creating unique anti-aging and oncology drugs for the US and Chinese markets.

AAPG: Ascentage Pharma Group International Intermediate Coverage Ratio 01/25/2025 - 10/30/2026
Finished products of Ascentage Pharma

This indicator assesses a business's ability to instantaneously settle short-term liabilities using only cash and accounts receivable, excluding low-liquidity inventories. For Ascentage Pharma Group (AAPG), this margin of safety is critical when financing the implementation of AI modules and laboratory robotics, reflecting the company's operational resilience through the current acid-test ratio.

Analysis of competing companies

ONC: Quick Ratio|Immediate Liquidity Halozyme Corp (HALO)|Quick Liquidity Revolution Medicines|CGON: Intermediate Coverage Ratio|Quick Liquidity Indicator URGN (UroGen Pharma)|BCAX (Bicara Therapeutics Inc) - Intermediate Coverage Ratio|Quick Ratio PSNL (Personalis Corp)|ERAS - Quick Liquidity Indicator|DCTH: Quick Liquidity Indicator|YMAB - Quick Ratio|Aura Biosciences (AURA) - Quick Liquidity|Candel Therapeutics, Inc. - Intermediate Coverage Ratio|ARAY (Accuray Inc.) - Quick Ratio|Immediate Liquidity SELLAS Life Sciences Group Inc. SLS|Quick Ratio ACTU|Quick Ratio citiusonc.com (CTOR)|Quick Liquidity TuHURA Biosciences HURA|Interim Coverage Ratio Protara Therapeutics Inc (TARA)|Fate Therapeutics Corp - Quick Ratio|Aadi Bioscience Inc (WHWK) - Quick Liquidity Indicator|TCRX: Quick Ratio|Immediate Liquidity Champions Oncology, Inc. (CSBR)|Quick Liquidity XBiotech Inc|Immediate Liquidity Ratio CVM (CEL-SCI Corp)|Quick Liquidity Indicator OSTX (OS Therapies Inc)|Intermediate Liquidity Ratio RADX|Quick Ratio ARTV (Artiva Biotherapeutics)|Quick Ratio Adlai Nortye Ltd ANL|Veru - Quick Ratio|Critical Liquidity Tempest Therapeutics Inc (TPST)|XLO: Quick Ratio|Immediate Liquidity Renovaro (RENB)|Quick Liquidity Indicator MURA|KAPA: Intermediate Coverage Ratio|Quick Liquidity OnKure Therapeutics Inc (OKUR)|GDTC: Critical Liquidity Ratio|Quick Ratio CRIS (Curis)|Intermediate Coverage Ratio APLM|Tharimmune, Inc. - Quick Ratio|ADVB - Quick Ratio|Genprex (GNPX) - Quick Liquidity|Calidi Biotherapeutics, Inc. - Intermediate Coverage Ratio|Quick Liquidity Sunshine Biopharma, Inc.|Quick Liquidity Indicator Xenetic Bio (XBIO)|Quick Ratio SLRX|Quick Ratio purple-biotech.com (PPBT)|American Oncology Network, Inc. - Quick Liquidity Indicator|Intermediate Coverage Ratio BGNE|Checkpoint Therapeutics, Inc - Quick Ratio|Critical Liquidity elevationoncology.com (ELEV)|icadmed.com (ICAD) - Quick Liquidity|Ikena Oncology - Intermediate Coverage Ratio|Quick Liquidity Notable Labs|Immediate Liquidity Viracta VIRX|Quick Liquidity Indicator MOR (MorphoSys Corp)|Quick Ratio NAYA Biosciences Corp (NAYA)|Quick Liquidity Ascentage Pharma Group AAPGV